ES2325291A1 - "uso de un extracto de silybum marianum" - Google Patents

"uso de un extracto de silybum marianum" Download PDF

Info

Publication number
ES2325291A1
ES2325291A1 ES200702600A ES200702600A ES2325291A1 ES 2325291 A1 ES2325291 A1 ES 2325291A1 ES 200702600 A ES200702600 A ES 200702600A ES 200702600 A ES200702600 A ES 200702600A ES 2325291 A1 ES2325291 A1 ES 2325291A1
Authority
ES
Spain
Prior art keywords
silybum marianum
marianum extract
extract
composition
silybum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES200702600A
Other languages
English (en)
Other versions
ES2325291B1 (es
Inventor
Floris Assumpta Bruna
Lopez Ricardo Gavilan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meda Pharma SL
Original Assignee
Madaus SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus SA filed Critical Madaus SA
Priority to ES200702600A priority Critical patent/ES2325291B1/es
Priority to PCT/EP2008/061647 priority patent/WO2009043671A1/en
Publication of ES2325291A1 publication Critical patent/ES2325291A1/es
Application granted granted Critical
Publication of ES2325291B1 publication Critical patent/ES2325291B1/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Uso de un extracto de Silybum marianum. Uso de una composición que comprende un extracto de Silybum marianum o un principio activo del mismo, para la preparación de un medicamento para la prevención y/o el tratamiento de la radiodermitis. Uso de la composición para administración vía tópica.
ES200702600A 2007-10-04 2007-10-04 "uso de un extracto de silybum marianum" Active ES2325291B1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES200702600A ES2325291B1 (es) 2007-10-04 2007-10-04 "uso de un extracto de silybum marianum"
PCT/EP2008/061647 WO2009043671A1 (en) 2007-10-04 2008-09-03 Use of a silybum marianum extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200702600A ES2325291B1 (es) 2007-10-04 2007-10-04 "uso de un extracto de silybum marianum"

Publications (2)

Publication Number Publication Date
ES2325291A1 true ES2325291A1 (es) 2009-08-31
ES2325291B1 ES2325291B1 (es) 2010-04-22

Family

ID=39838713

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200702600A Active ES2325291B1 (es) 2007-10-04 2007-10-04 "uso de un extracto de silybum marianum"

Country Status (2)

Country Link
ES (1) ES2325291B1 (es)
WO (1) WO2009043671A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4620532A3 (en) 2012-07-05 2025-10-22 Nutramax Laboratories, Inc. Compositions comprising sulforaphane or a sulforaphane precursor and a mushroom extract or powder
CN105796831A (zh) * 2016-04-19 2016-07-27 北京欣普迪生物科技有限公司 医用射线防护剂及其制备方法
CN106176845A (zh) * 2016-08-30 2016-12-07 青海民族大学 柳兰抑制cdc25酶有效部位及制法和应用
CN106344631A (zh) * 2016-08-30 2017-01-25 青海民族大学 柳兰有效部位及其制备方法和应用
CN106176843A (zh) * 2016-08-30 2016-12-07 青海民族大学 柳兰抑制hdac1酶有效部位及制法和应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002067878A2 (en) * 2001-02-21 2002-09-06 Skinceuticals, Inc. Use of mil thistle extract in skin care compositions
WO2003088986A1 (en) * 2002-04-16 2003-10-30 Isis Innovation Limited Curcumin for the prevention and/or treatment of tissue damage
ES2254647T3 (es) * 2001-03-02 2006-06-16 Indena S.P.A. Composicines farmaceuticas y cosmeticas para la proteccion de la piel de daños inducidos por radiaciones solares.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT407821B (de) * 1998-03-24 2001-06-25 Franz Dr Stueckler Mittel auf der basis von naturstoffen
JP2003171310A (ja) * 2002-05-02 2003-06-20 Noevir Co Ltd 皮膚バリア機能強化剤
WO2007041327A1 (en) * 2005-10-01 2007-04-12 Elc Management Llc Compositions comprising hypsizygus ulmarius extract

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002067878A2 (en) * 2001-02-21 2002-09-06 Skinceuticals, Inc. Use of mil thistle extract in skin care compositions
ES2254647T3 (es) * 2001-03-02 2006-06-16 Indena S.P.A. Composicines farmaceuticas y cosmeticas para la proteccion de la piel de daños inducidos por radiaciones solares.
WO2003088986A1 (en) * 2002-04-16 2003-10-30 Isis Innovation Limited Curcumin for the prevention and/or treatment of tissue damage

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ABASCAL, K. et al. "The many faces of Silybum marianum (Milk thistle): Part 1 - Treating cancer and hyperlipidemia and restoring kidney funtions". Alternative & Complementary therapies, 2003. Vol. 9, nº 4, páginas 170-175. ISSN 1076-2809. Ver página 171, columna 1 y página 172, columna 2, párrafo 1. *
GREENLEE, H. et al. "Clinical applications of Silybum marianum in Oncology". Integrative Cancer Therapies, junio 2007. Vol. 6, nº 2, páginas 158-165. ISSN 1534-7354. Ver página 161, columna 1 y página 162, columna 2. *
LI, L-H et al. "Silymarin prevents UV irradiation-induced A375- S2 cell apoptosis". Biol. Pharm. Bull. 2004. Vol. 27, nº 7, páginas 1031-1036. *
MARGALEF ESTEVE, M. et al. "Study of an active complex for skin ageing prevention". Parfumerie und Kosmetik, 1991. Vol. 72, nº 12, páginas 820,822,824,826,828-9. ISSN 0031-1952. *
McDOUGALL, CAROL J. et al. "Management of radiation dermatitis in a patient after mastectomy". Journal of Wound, Ostomy and Continence Nursing, 2005. Vol. 32, nº 5, páginas 337-340. ISSN 1071-5754. *

Also Published As

Publication number Publication date
ES2325291B1 (es) 2010-04-22
WO2009043671A1 (en) 2009-04-09

Similar Documents

Publication Publication Date Title
CL2008001855A1 (es) Compuestos ciclicos condensados derivados del boro; composicion farmaceutica; y uso en el tratamiento y/o prevencion de una enfermedad infecciosa.
MX2009010289A (es) Composiciones para administracion nasal.
CL2008000442A1 (es) Composicion farmaceutica que comprende a un quitosano, un ingrediente activo cosmetico o farmaceutico, y un solvente volatil; y su uso para tratar psoriasis, micosis entre otras enfermedades.
BRPI0806531A2 (pt) Composto, composição farmacêutica, agente terapêutico, e, uso do composto.
CY1112320T1 (el) Τιτλοδοτηση της ταπενταδολης
CL2011000170A1 (es) Composicion farmaceutica solida y estabilizada que comprende un ingrediente farmaceuticamente activo, oxido de titanio y un plastificante; procedimiento para estabilizar la composicion farmaceutica durante una irradiacion luminosa.
ECSP088239A (es) Composición de liberación de fármaco sostenida
ECSP088240A (es) Composición de trazodona para administración una vez por día
CL2007001724A1 (es) Uso de un estrogeno para el tratamiento de enfermedades, condiciones o sintomas asociados con niveles deficientes de estrogenos en una mujer; composicion farmaceutica que comprende unidades de dosificacion diarias de hemidrato de estradiol > 0,75 y 1
BR0312573A (pt) Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina
AR062522A1 (es) Tratamiento de desordenes en cartilagos
ECSP10010224A (es) Formulaciones líquidas de hormona luteinizante (lh).
BRPI0815577A2 (pt) Peptídeo foxm1 e agente medicinal compreendendo o mesmo.
UY33984A (es) Uso de 2,3-dihidroimidazo [1,2-c] quinazolinas sustituidas
CL2011000798A1 (es) Uso de etexilato de dabigatran o una sal del mismo para preparar un medicamento util para la prevencion del ictus en pacientes que padecen fibrilacion auricular.
CL2007003356A1 (es) Compuestos derivados de benzopirazoles; proceso para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos y otro agente activo; y su uso para el tratamiento del asma, inflamacion, entre otras enfermedades.
AR071728A1 (es) Terapia con intervalos para el tratamiento del tinnitus
BRPI1009392A2 (pt) "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica."
MX2010005012A (es) Composiciones para el tratamieno y prevencion de inflamacion de los parpados que comprenden un ingrediente osmoticamente activo y un vasocosntrictor.
AR077125A1 (es) Combinaciones farmaceuticas utiles para tratar el vhc
BR112012013164A2 (pt) composições farmacêuticas para o estímulo de células-tronco
EA201170512A1 (ru) Композиция для перорального введения
BRPI0816798A2 (pt) composto, composição farmacêutica, métodos para inibir a ação do glicogênio sintase cinase-3, e para tratar, prevenir ou melhorar uma doença, uso de um composto, e, artigo de fabricação
ES2325291A1 (es) "uso de un extracto de silybum marianum"
AR072951A1 (es) Uso de dronedarona o una sal aceptable farmaceuticamente de esta, para la preparacion de un medicamento para regular el nivel de potasio en la sangre

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20090831

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2325291B1

Country of ref document: ES

PC2A Transfer of patent

Owner name: ROTTAPHARM, S.L. UNIPERSONAL

Effective date: 20130524